BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27483449)

  • 1. Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis.
    Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson PJ; Alfredsson L; Klareskog L; Rönnelid J; Padyukov L
    Arthritis Rheumatol; 2017 Jan; 69(1):58-69. PubMed ID: 27483449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.
    Kokkonen H; Brink M; Hansson M; Lassen E; Mathsson-Alm L; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2015 May; 17(1):125. PubMed ID: 25990747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
    Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.
    Li X; Wang Z; Yi H; Xie J; Zhu N
    Clin Rheumatol; 2020 Apr; 39(4):1111-1120. PubMed ID: 31858337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.
    Quirke AM; Perry E; Cartwright A; Kelly C; De Soyza A; Eggleton P; Hutchinson D; Venables PJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2335-42. PubMed ID: 26017630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
    Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.
    Brink M; Hansson M; Mathsson-Alm L; Wijayatunga P; Verheul MK; Trouw LA; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2016 Feb; 18():43. PubMed ID: 26860413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
    Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; van Vollenhoven RF; Lundberg K
    Ann Rheum Dis; 2016 Feb; 75(2):356-61. PubMed ID: 25550338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
    Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC
    Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
    Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
    Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autoantibody response to cyclic citrullinated collagen type II peptides in rheumatoid arthritis.
    Liang B; Ge C; Lönnblom E; Lin X; Feng H; Xiao L; Bai J; Ayoglu B; Nilsson P; Nandakumar KS; Zhao M; Holmdahl R
    Rheumatology (Oxford); 2019 Sep; 58(9):1623-1633. PubMed ID: 30892636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
    Cabrera-Villalba S; Gomara MJ; Cañete JD; Ramírez J; Salvador G; Ruiz-Esquide V; Hernández MV; Inciarte-Mundo J; Haro I; Sanmartí R
    Arthritis Res Ther; 2017 Jun; 19(1):141. PubMed ID: 28619044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
    Geraldino-Pardilla L; Russo C; Sokolove J; Robinson WH; Zartoshti A; Van Eyk J; Fert-Bober J; Lima J; Giles JT; Bathon JM
    Rheumatology (Oxford); 2017 Apr; 56(4):534-540. PubMed ID: 27994093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
    Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
    Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
    Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.